{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:04:38Z","timestamp":1790258678580,"version":"4.1.0"},"reference-count":237,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015362","name":"Amicus Therapeutics Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neubiorev.2026.106931","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:34:37Z","timestamp":1788312877000},"page":"106931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Disruptions in speech, language and social communication in lysosomal storage diseases"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0583-8945","authenticated-orcid":false,"given":"Georgina","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel van","family":"Gool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlton","family":"Gaskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaymin","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S0012162206000570","article-title":"Standardized assessment of behavior and adaptive living skills in juvenile neuronal ceroid lipofuscinosis","volume":"48","author":"Adams","year":"2006","journal-title":"Dev. Med. & Child. Neurol."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106931_bib2","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1177\/0883073813494813","article-title":"null n. Neurobehavioral features and natural history of juvenile neuronal ceroid lipofuscinosis (Batten Disease)","volume":"28","author":"Adams","year":"2013","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106931_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00051","article-title":"Mitochondria: an integrative hub coordinating circadian rhythms, metabolism, the microbiome, and immunity","volume":"8","author":"Aguilar-L\u00f3pez","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"issue":"13","key":"10.1016\/j.neubiorev.2026.106931_bib4","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.neubiorev.2026.106931_bib5","first-page":"1","article-title":"Prevalence and Novel Mutations of Lysosomal Storage Disorders in United Arab Emirates","volume":"10","author":"Al-Jasmi","year":"2013"},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106931_bib6","doi-asserted-by":"crossref","DOI":"10.2196\/28619","article-title":"Mucopolysaccharidosis type i disease prevalence among patients with idiopathic short stature in Saudi Arabia: protocol for a multicenter cross-sectional study","volume":"10","author":"Alsafadi","year":"2021","journal-title":"JMIR Res. Protoc."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41531-025-01050-8","article-title":"Digital phenotyping of Parkinson\u2019s disease via natural language processing","volume":"11","author":"Aresta","year":"2025","journal-title":"npj Park. 's. Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(99)00076-9","article-title":"Aspartylglycosaminuria: biochemistry and molecular biology","volume":"1455","author":"Aronson","year":"1999","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1086\/303077","article-title":"The spectrum of <em>SLC17A5<\/em>-gene mutations resulting in free sialic acid\u2013storage diseases indicates some genotype-phenotype correlation","volume":"67","author":"Aula","year":"2000","journal-title":"Am. J. Human. Genet."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106931_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur. J. Human. Genet."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2788.2005.00659.x","article-title":"Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis","volume":"49","author":"B\u00e4ckman","year":"2005","journal-title":"J. Intellect. Disabil. Res."},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106931_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00431-005-1678-z","article-title":"Familial X-linked cardiomyopathy (Danon disease): diagnostic confirmation by mutation analysis of the LAMP2gene","volume":"164","author":"Balmer","year":"2005","journal-title":"Eur. J. Pediatr."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13052-018-0561-2","article-title":"Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses","volume":"44","author":"Barone","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.neubiorev.2026.106931_bib14","article-title":"Diagnosis, treatment, and follow-up of a case of Wolman disease with hemophagocytic lymphohistiocytosis","volume":"30","author":"Baronio","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.neubiorev.2026.106931_bib15","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3389\/fncel.2019.00196","article-title":"Dual role of autophagy in diseases of the central nervous system","volume":"13","author":"Bar-Yosef","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-018-0872-9","article-title":"A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life","volume":"13","author":"Bascou","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2026.106931_bib17","unstructured":"Bayles K.A., Tomoeda C.K. Arizona Battery for Communication Disorders of Dementia. Pro-Ed; 2020."},{"key":"10.1016\/j.neubiorev.2026.106931_bib18","series-title":"Bayley Scales of Infant and Toddler Development-III","author":"Bayley","year":"2006"},{"key":"10.1016\/j.neubiorev.2026.106931_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2021.100879","article-title":"Niemann-pick disease, type C: diagnosis, management and disease-targeted therapies in development","volume":"37","author":"Berry-Kravis","year":"2021","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106931_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2017.12.014","article-title":"Long-term treatment of niemann-pick type C1 disease with intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin","volume":"80","author":"Berry-Kravis","year":"2018","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106931_bib21","series-title":"Augmentative and Alternative Communication: Supporting Children & Adults with Complex Communication Needs 4th Edition","author":"Beukelman","year":"2013"},{"key":"10.1016\/j.neubiorev.2026.106931_bib22","first-page":"614","article-title":"Children\u2019s communication checklist (CCC-2)","author":"Bishop","year":"2013","journal-title":"Psychol. Corp."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106931_bib23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd.2018.109","article-title":"Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing","volume":"17","author":"Boland","year":"2018","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.neubiorev.2026.106931_bib24","first-page":"S205","article-title":"Neural and physiological changes following intensive voice therapy in children with motor speech disorders secondary to cerebral palsy: 525","volume":"30","author":"Boliek","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13023-015-0286-x","article-title":"Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation","volume":"10","author":"Borgwardt","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jpeds.2013.01.052","article-title":"The global school adaptation score: a new neurodevelopmental assessment tool for very preterm children at five years of age","volume":"163","author":"Boussicault","year":"2013","journal-title":"J. Pediatr."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106931_bib27","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/14656566.2023.2215386","article-title":"Current advancements in therapy for Niemann-Pick disease: progress and pitfalls","volume":"24","author":"Bremova-Ertl","year":"2023","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.neubiorev.2026.106931_bib28","article-title":"Successful use of an eye gaze AAC communication board by a young adult with advanced Sanfilippo Syndrome (MPS IIIA): Case report","volume":"5","author":"Brennan","year":"2024","journal-title":"Ther. Adv. Rare Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/87565641.2018.1564310","article-title":"Beyond the bayley: neurocognitive assessments of development during infancy and toddlerhood","volume":"44","author":"Brito","year":"2019","journal-title":"Dev. Neuropsychol."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/07434618.2024.2327044","article-title":"A scoping review of AAC interventions for children and young adults with simultaneous visual and motor impairments: clinical and research Implications","volume":"40","author":"Brittlebank","year":"2024","journal-title":"Augment. Altern. Commun."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/09297040903146966","article-title":"NEPSY-II: a developmental neuropsychological assessment, second edition","volume":"16","author":"Brooks","year":"2009","journal-title":"Child Neuropsychol."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10545-013-9661-8","article-title":"Natural history of Sanfilippo syndrome type A","volume":"37","author":"Buhrman","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2026.106931_bib33","series-title":"Oral and Written Language Scales\u2013Second Edition (OWLS-II)","author":"Carrow-Woolfolk","year":"2011"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/nan.12587","article-title":"Review: danon disease: review of natural history and recent advances","volume":"46","author":"Cenacchi","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib35","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2798","article-title":"Ages and stages questionnaire at 3 years for predicting IQ at 5\u20136 years","volume":"139","author":"Charkaluk","year":"2017","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1186\/s12864-024-10724-1","article-title":"Mucopolysaccharidosis type I: founder effect of the p.P533R mutation in North Africa","volume":"25","author":"Chkioua","year":"2024","journal-title":"BMC Genom."},{"key":"10.1016\/j.neubiorev.2026.106931_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.infbeh.2016.07.003","article-title":"Communication in the second and third year of life: relationships between nonverbal social skills and language","volume":"44","author":"Cochet","year":"2016","journal-title":"Infant. Behav. Dev."},{"key":"10.1016\/j.neubiorev.2026.106931_bib38","series-title":"Social Responsiveness Scale (SRS-2)","first-page":"2919","author":"Constantino","year":"2013"},{"key":"10.1016\/j.neubiorev.2026.106931_bib39","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A8973","article-title":"Neuroimaging spectrum of GM1 gangliosidosis with description of novel imaging signs","author":"Coppola","year":"2026","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.3021","article-title":"The cellular pathology of lysosomal diseases","volume":"226","author":"Cox","year":"2012","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10545-012-9572-0","article-title":"Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders","volume":"36","author":"Cross","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10545-012-9572-0","article-title":"Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders","volume":"36","author":"Cross","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"issue":"03","key":"10.1016\/j.neubiorev.2026.106931_bib43","first-page":"198","article-title":"Cognitive and behavioral profiles of children with aspartylglucosaminuria: a case series","volume":"20","author":"Crowe","year":"2021","journal-title":"J. Pediatr. Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib44","doi-asserted-by":"crossref","DOI":"10.1097\/RMR.0000000000000174","article-title":"Neuroimaging findings in lysosomal disorders: 2018 update","volume":"27","author":"D\u2019Arco","year":"2018","journal-title":"Top. Magn. Reson. Imaging"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib45","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10545-007-0595-x","article-title":"A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease","volume":"30","author":"Davies","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib46","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10545-012-9560-4","article-title":"Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review","volume":"36","author":"Debs","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2026.106931_bib47","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fncel.2020.00283","article-title":"Shifting developmental trajectories during critical periods of brain formation","volume":"14","author":"Dehorter","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13023-021-02134-3","article-title":"Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up","volume":"16","author":"Demaret","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib49","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1044\/1092-4388(2006\/061)","article-title":"Maturation of speech and language functional neuroanatomy in pediatric normal controls","volume":"49","author":"Devous","year":"2006","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106931_bib50","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S1474-4422(21)00241-6","article-title":"Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial","volume":"20","author":"Diaz-Manera","year":"2021","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106931_bib51","article-title":"GM1 gangliosidosis type II: results of a 10-year prospective study","volume":"26","author":"D'Souza","year":"2024","journal-title":"Genet. Med."},{"key":"10.1016\/j.neubiorev.2026.106931_bib52","series-title":"Motor speech disorders: Substrates, differential diagnosis, and management","author":"Duffy","year":"2012"},{"key":"10.1016\/j.neubiorev.2026.106931_bib53","series-title":"Peabody picture vocabulary test [Measurement instrument]","author":"Dunn","year":"2019"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0960-8966(94)90025-6","article-title":"Lysosomal glycogen storage with normal acid maltase: a familial study with successful heart transplant","volume":"4","author":"Dworzak","year":"1994","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mdc3.12573","article-title":"The spectrum of movement disorders in childhood-onset lysosomal storage diseases","volume":"5","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1017\/S1041610212001664","article-title":"Communication skills training in dementia care: a systematic review of effectiveness, training content, and didactic methods in different care settings","volume":"25","author":"Eggenberger","year":"2013","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neubiorev.2026.106931_bib57","unstructured":"Ehrler D.J., McGhee R.L. PTONI: Primary Test of Nonverbal Intelligence. Pro-ed Austin, TX; 2008."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106931_bib58","doi-asserted-by":"crossref","DOI":"10.1097\/MS9.0000000000002611","article-title":"Neurological manifestations of lysosomal storage diseases","volume":"86","author":"Elendu","year":"2024","journal-title":"Ann. Med. Surg."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2017-000182","article-title":"Incidence of infantile pompe disease in the maroon population of French Guiana","volume":"2","author":"Elenga","year":"2018","journal-title":"BMJ Paediatr. Open."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/13682828009112541","article-title":"Frenchay Dysarthria Assessment","volume":"15","author":"Enderby","year":"1980","journal-title":"Br. J. Disord. Commun."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib61","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s13023-021-02115-6","article-title":"International consensus on clinical severity scale use in evaluating Niemann\u2013Pick disease Type C in paediatric and adult patients: results from a Delphi Study","volume":"16","author":"Evans","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/08830738251346348","article-title":"Convergent validity of the fine motor, speech, and cognitive domains of the 5-domain niemann-pick disease type C clinical severity scale","volume":"41","author":"Farmer","year":"2025","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.neubiorev.2026.106931_bib63","series-title":"Second Ed.","article-title":"MacArthur-Bates Communicative Development Inventories, (CDIs)","author":"Fenson","year":"2006"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2016.07.011","article-title":"Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): expert recommendations for early detection and laboratory diagnosis","volume":"119","author":"Fietz","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1479-7364-5-3-156","article-title":"Lysosomal storage disorders: molecular basis and laboratory testing","volume":"5","author":"Filocamo","year":"2011","journal-title":"Human. Genom."},{"issue":"R2","key":"10.1016\/j.neubiorev.2026.106931_bib66","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1093\/hmg\/ddy155","article-title":"The pathogenesis of lysosomal storage disorders: beyond the engorgement of lysosomes to abnormal development and neuroinflammation","volume":"27","author":"Fiorenza","year":"2018","journal-title":"Human. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2026.106931_bib67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatry Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib68","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1044\/1092-4388(2011\/10-0235)","article-title":"Intensive voice treatment (LSVT LOUD) for children with spastic cerebral palsy and dysarthria","volume":"55","author":"Fox","year":"2012","journal-title":"J. Speech Lang. Hear. Res."},{"key":"10.1016\/j.neubiorev.2026.106931_bib69","first-page":"S205","article-title":"Technology-enhanced maintenance practice following intensive voice therapy (LSVT LOUD) in children with cerebral palsy and dysarthria: 526","volume":"30","author":"Fox","year":"2015","journal-title":"Mov. Disord."},{"issue":"04","key":"10.1016\/j.neubiorev.2026.106931_bib70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-2006-955118","article-title":"The science and practice of LSVT\/LOUD: neural plasticity-principled approach to treating individuals with parkinson disease and other neurological disorders","volume":"27","author":"Fox","year":"2006","journal-title":"Semin. Speech & Lang."},{"key":"10.1016\/j.neubiorev.2026.106931_bib71","first-page":"2014","article-title":"Reducing maladaptive behaviors in preschool-aged children with autism spectrum disorder using the early start denver model","volume":"2","author":"Fulton","year":"2014","journal-title":"Orig. Res. Front. Pediatr."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106931_bib72","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib73","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10803-011-1212-2","article-title":"A meta-analysis of single case research studies on aided augmentative and alternative communication systems with individuals with autism spectrum disorders","volume":"42","author":"Ganz","year":"2012","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neubiorev.2026.106931_bib74","doi-asserted-by":"crossref","unstructured":"Gao Y., Fu J., Guo L., Liu H. Leveraging Large Language Models for Spontaneous Speech-Based Suicide Risk Detection. arXiv preprint arXiv:250700693. 2025;","DOI":"10.21437\/Interspeech.2025-1483"},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106931_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47060417","article-title":"Neuroinflammation: mechanisms, dual roles, and therapeutic strategies in neurological disorders","volume":"47","author":"Garc\u00eda-Dom\u00ednguez","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib76","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","article-title":"Consensus clinical management guidelines for Niemann-Pick disease type C","volume":"13","author":"Geberhiwot","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2026.106931_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2021.664650","article-title":"The effect of focal damage to the right medial posterior cerebellum on word and sentence comprehension and production","volume":"15","author":"Geva","year":"2021","journal-title":"Front. Human. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib78","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2352-4642(17)30087-1","article-title":"Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS","volume":"2","author":"Giugliani","year":"2018","journal-title":"Lancet Child. Adolesc. Health"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib79","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41562-025-02105-9","article-title":"A unified acoustic-to-speech-to-language embedding space captures the neural basis of natural language processing in everyday conversations","volume":"9","author":"Goldstein","year":"2025","journal-title":"Nat. Human. Behav."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106931_bib80","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/neurolint17070098","article-title":"Advances in diagnosis, pathological mechanisms, clinical impact, and future therapeutic perspectives in tay\u2013sachs disease","volume":"17","author":"Gonz\u00e1lez-S\u00e1nchez","year":"2025","journal-title":"Neurol. Int."},{"issue":"S1","key":"10.1016\/j.neubiorev.2026.106931_bib81","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1002\/ajh.24063","article-title":"Gaucher disease types 1 and 3: phenotypic characterization of large populations from the ICGG Gaucher Registry","volume":"90","author":"Grabowski","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib82","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1086\/301931","article-title":"The Nova Scotia (Type D) form of niemann-pick disease is caused by a G3097\u2192T transversion in NPC1","volume":"63","author":"Greer","year":"1998","journal-title":"Am. J. Human. Genet."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108519","article-title":"Monitoring and integrated care coordination of patients with alpha-mannosidosis: a global Delphi consensus study","volume":"142","author":"Guffon","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2026.106931_bib84","unstructured":"Haley S.M. Pediatric Evaluation of Disability Inventory (PEDI): Development, standardization and administration manual. (No Title). 1992;"},{"key":"10.1016\/j.neubiorev.2026.106931_bib85","series-title":"Adaptive behavior assessment system (ABAS-3): Manual","author":"Harrison","year":"2015"},{"key":"10.1016\/j.neubiorev.2026.106931_bib86","series-title":"Verbal motor production assessment for children","author":"Hayden","year":"1999"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib87","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155","author":"H\u00e9ron","year":"2011","journal-title":"Am. J. Med. Genet. Part. A"},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib88","article-title":"Rapid and long-lasting efficacy of high-dose ambroxol therapy for neuronopathic Gaucher disease: a case report and literature review","volume":"12","author":"Higashi","year":"2024","journal-title":"Mol. Genet. & Genom. Med."},{"issue":"20","key":"10.1016\/j.neubiorev.2026.106931_bib89","doi-asserted-by":"crossref","first-page":"e2148","DOI":"10.1212\/WNL.0000000000009441","article-title":"Severe childhood speech disorder","volume":"94","author":"Hildebrand","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib90","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"WF. Prevalence of lysosomal storage disorders","volume":"281","author":"Hopwood","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2017.04.011","article-title":"Infantile gangliosidoses: mapping a timeline of clinical changes","volume":"121","author":"Jarnes Utz","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib92","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/gim.2015.108","article-title":"Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants","volume":"18","author":"Jones","year":"2016","journal-title":"Genet. Med."},{"issue":"19","key":"10.1016\/j.neubiorev.2026.106931_bib93","first-page":"2307","article-title":"Tay-Sachs disease- carrier screening, prenatal diagnosis, and the molecular era: an international perspective","volume":"270","author":"Kaback","year":"1993","journal-title":"1970 1993. JAMA"},{"key":"10.1016\/j.neubiorev.2026.106931_bib94","unstructured":"Kaiser A.P. Parent-implemented language intervention: An environmental system perspective. In: {C}{C}Kaiser A.P., Gray D., eds{C}{C}. Enhancing children\u2019s communication: research foundations for intervention Brookes; 1993:63\u201384."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib95","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1044\/1092-4388(2012\/11-0231)","article-title":"Parent-implemented enhanced milieu teaching with preschool children who have intellectual disabilities","volume":"56","author":"Kaiser","year":"2013","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106931_bib96","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.V12102170","article-title":"Characterization of a PUtative Founder Mutation That Accounts for the High Incidence of Cystinosis in Brittany","volume":"12","author":"Kalatzis","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib97","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/archderm.1993.01680250072009","article-title":"Angiokeratoma Corporis Diffusum With Glycopeptiduria due to Deficient Lysosomal a-N-Acetylgalactosaminidase Activity: Clinical, Morphologic, and Biochemical Studies","volume":"129","author":"Kanzaki","year":"1993","journal-title":"Arch. Dermatol."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106931_bib98","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10803-010-0955-5","article-title":"Randomized controlled caregiver mediated joint engagement intervention for toddlers with autism","volume":"40","author":"Kasari","year":"2010","journal-title":"J. Autism Dev. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib99","doi-asserted-by":"crossref","first-page":"130","DOI":"10.20517\/jtgg.2025.10","article-title":"Comparative case series demonstrating disease modifying outcome with early ambroxol and enzyme replacement therapy in acute neuronopathic Gaucher disease","volume":"9","author":"Katherine","year":"2025","journal-title":"J. Transl. Genet. Genom."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.108119","article-title":"Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease","volume":"141","author":"Kenney-Jung","year":"2024","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib101","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/jpm12050665","article-title":"Natural history and molecular characteristics of korean patients with mucopolysaccharidosis type III","volume":"12","author":"Kim","year":"2022","journal-title":"J. Pers. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib102","article-title":"Auditory phenotype of Niemann-pick disease, type C1","volume":"35","author":"King","year":"2014","journal-title":"Ear Hear."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib103","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib104","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","article-title":"Pompe disease: from basic science to therapy","volume":"15","author":"Kohler","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106931_bib105","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1515\/jpem-2019-0505","article-title":"Mucopolysaccharidosis III in Mainland China: natural history, clinical and molecular characteristics of 34 patients","volume":"33","author":"Kong","year":"2020","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib106","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13023-022-02429-z","article-title":"Qualitative analysis of patient interviews on the burden of neuronopathic Gaucher disease in Japan","volume":"17","author":"Koto","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2026.106931_bib107","doi-asserted-by":"crossref","unstructured":"Kouhashi M., Yukawa K., Yano N., et al. A 37-Year-Old Man With Intellectual Disability Discovered to Have Aspartylglucosaminuria. Neurology Genetics. (n.d). 10(3):e200161. doi:10.1212\/NXG.0000000000200161.","DOI":"10.1212\/NXG.0000000000200161"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib108","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/biom11030400","article-title":"Lysosomal functions in glia associated with neurodegeneration","volume":"11","author":"Kreher","year":"2021","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib109","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neuron.2010.08.038","article-title":"Brain mechanisms in early language acquisition","volume":"67","author":"Kuhl","year":"2010","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib110","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/cells10020420","article-title":"Potential treatment of lysosomal storage disease through modulation of the mitochondrial-lysosomal axis","volume":"10","author":"Kuk","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib111","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1044\/2024_JSLHR-24-00515","article-title":"Early identification of language disorders using natural language processing and machine learning: challenges and emerging approaches","volume":"68","author":"Lammert","year":"2025","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib112","first-page":"8","article-title":"Neuropsychological test battery in the follow-up of patients with juvenile neuronal ceroid lipofuscinosis","volume":"45","author":"Lamminranta","year":"2001","journal-title":"J. Intellect. Disabil. Res."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib113","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/gim.2014.120","article-title":"Fabry disease in infancy and early childhood: a systematic literature review","volume":"17","author":"Laney","year":"2015","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib114","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2019.12.012","article-title":"The natural history of Type 1 infantile GM1 gangliosidosis: a literature-based meta-analysis","volume":"129","author":"Lang","year":"2020","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib115","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1044\/1092-4388(2004\/069)","article-title":"The efficacy of treatment for children with developmental speech and language delay\/disorder","volume":"47","author":"Law","year":"2004","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"17","key":"10.1016\/j.neubiorev.2026.106931_bib116","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.3390\/ijms21176213","article-title":"GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies","volume":"21","author":"Leal","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib117","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/17549507.2014.894123","article-title":"Implementing two treatment approaches to childhood dysarthria","volume":"16","author":"Levy","year":"2014","journal-title":"Int. J. Speech-Lang. Pathol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib118","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/10400435.2011.648717","article-title":"Supporting the communication, language, and literacy development of children with complex communication needs: state of the science and future research priorities","volume":"24","author":"Light","year":"2012","journal-title":"Assist. Technol."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106931_bib119","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/biom15101448","article-title":"Mucopolysaccharidoses\u2014what clinicians need to know: a clinical, biochemical, and molecular overview","volume":"15","author":"Lipi\u0144ski","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.neubiorev.2026.106931_bib120","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fnins.2024.1455085","article-title":"Mapping subcortical brain lesions, behavioral and acoustic analysis for early assessment of subacute stroke patients with dysarthria","volume":"18","author":"Liu","year":"2025","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib121","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/jpc.15250","article-title":"Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: insights from the largest cohort in the world","volume":"57","author":"Louren\u00e7o","year":"2021","journal-title":"J. Paediatr. Child. Health"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12833","article-title":"Unifying biology of neurodegeneration in lysosomal storage diseases","volume":"48","author":"Ludlaim","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib123","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ymgme.2009.06.005","article-title":"Substrate reduction therapy in juvenile GM2 gangliosidosis","volume":"98","author":"Maegawa","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106931_bib124","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1111\/ene.15871","article-title":"Efficacy and safety of miglustat in the treatment of GM2 gangliosidosis: a systematic review","volume":"30","author":"Mansouri","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"s457","key":"10.1016\/j.neubiorev.2026.106931_bib125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1651-2227.2008.00651.x","article-title":"Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective","volume":"97","author":"Martin","year":"2008","journal-title":"Acta Paediatr."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1044\/1058-0360(2008\/007)","article-title":"A review of standardized tests of nonverbal oral and speech motor performance in children","volume":"17","author":"McCauley","year":"2008","journal-title":"Am. J. Speech-Lang. Pathol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib127","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13023-024-03256-0","article-title":"Measuring health related quality of life (HRQoL) in Lysosomal Storage Disorders (LSDs): a rapid scoping review of available tools and domains","volume":"19","author":"McDool","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib128","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1044\/1092-4388(2011\/10-0130)","article-title":"The intelligibility in context scale: validity and reliability of a subjective rating measure","volume":"55","author":"McLeod","year":"2012","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106931_bib129","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/jimd.12428","article-title":"Efficacy and safety of arimoclomol in Niemann-Pick disease type C: results from a double-blind, randomised, placebo-controlled, multinational phase 2\/3 trial of a novel treatment","volume":"44","author":"Mengel","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1044\/1092-4388(2006\/021)","article-title":"The impact of augmentative and alternative communication intervention on the speech production of individuals with developmental disabilities: a research review","volume":"49","author":"Millar","year":"2006","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib131","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000355864","article-title":"Changes in voice quality after speech-language therapy intervention in older children with cerebral palsy","volume":"65","author":"Miller","year":"2014","journal-title":"Folia Phoniatr. Et. Logop."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106931_bib132","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0883073813494268","article-title":"Classification and natural history of the neuronal ceroid lipofuscinoses","volume":"28","author":"Mink","year":"2013","journal-title":"J. Child. Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib133","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","article-title":"Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis","volume":"18","author":"Mole","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib134","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13023-021-01813-5","article-title":"Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients","volume":"16","author":"Mole","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106931_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078694","article-title":"A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease","volume":"8","author":"Morgan","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.neubiorev.2026.106931_bib136","article-title":"Intervention for dysarthria associated with acquired brain injury in children and adolescents","volume":"3","author":"Morgan","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib137","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/07434618.2018.1458900","article-title":"A systematic quality review of high-tech AAC interventions as an evidence-based practice","volume":"34","author":"Morin","year":"2018","journal-title":"Augment. Altern. Commun."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib138","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12838","article-title":"Speech, language and non-verbal communication in CLN2 and CLN3 batten disease","volume":"48","author":"Morison","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib139","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatol. (Oxf. )"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib140","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12790","article-title":"Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase-IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis II","volume":"48","author":"Muenzer","year":"2025","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Management atICPot, I ToM. mucopolysaccharidosis i: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib142","article-title":"Lysosomal storage disorders with neurological manifestations","volume":"1","author":"Munjal","year":"2022","journal-title":"Rare Dis. Orphan Drugs J."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib143","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/136384999289630","article-title":"Real-time continuous visual biofeedback in the treatment of speech breathing disorders following childhood traumatic brain injury: report of one case","volume":"3","author":"Murdoch","year":"1999","journal-title":"Pediatr. Rehabil."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib144","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/s13023-022-02484-6","article-title":"Sanfilippo syndrome: consensus guidelines for clinical care","volume":"17","author":"Muschol","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106931_bib145","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/14712598.2019.1607837","article-title":"An update on gene therapy for lysosomal storage disorders","volume":"19","author":"Nagree","year":"2019","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib146","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41390-020-0924-4","article-title":"PROMPT intervention for children with severe speech motor delay: a randomized control trial","volume":"89","author":"Namasivayam","year":"2021","journal-title":"Pediatr. Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib147","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib148","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/01.GIM.0000154300.84107.75","article-title":"Late-onset Tay-Sachs disease: phenotypic characterization and genotypic correlations in 21 affected patients","volume":"7","author":"Neudorfer","year":"2005","journal-title":"Genet. Med."},{"issue":"7-8","key":"10.1016\/j.neubiorev.2026.106931_bib149","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jocn.14697","article-title":"Communication training and its effects on carer and care-receiver outcomes in dementia settings: a systematic review","volume":"28","author":"Nguyen","year":"2019","journal-title":"J. Clin. Nurs."},{"issue":"06","key":"10.1016\/j.neubiorev.2026.106931_bib150","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0043-1770143","article-title":"Language delay in patients with CLN2 disease: could it support earlier diagnosis?","volume":"54","author":"Nickel","year":"2023","journal-title":"Neuropediatrics"},{"issue":"8","key":"10.1016\/j.neubiorev.2026.106931_bib151","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S2352-4642(18)30179-2","article-title":"Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study","volume":"2","author":"Nickel","year":"2018","journal-title":"Lancet Child. & Adolesc. Health"},{"key":"10.1016\/j.neubiorev.2026.106931_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.734878","article-title":"GM1 gangliosidosis-a mini-review","volume":"12","author":"Nicoli","year":"2021","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106931_bib153","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1044\/2018_JSLHR-L-17-0132","article-title":"Effects of interventions that include aided augmentative and alternative communication input on the communication of individuals with complex communication needs: a meta-analysis","volume":"61","author":"O'Neill","year":"2018","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib154","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s40489-021-00249-8","article-title":"A systematic review of family-mediated social communication interventions for young children with autism","volume":"9","author":"Pacia","year":"2022","journal-title":"Rev. J. Autism Dev. Disord."},{"issue":"66, 2015","key":"10.1016\/j.neubiorev.2026.106931_bib155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106931_bib156","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/mt.2015.62","article-title":"Pharmacological chaperone therapy: preclinical development, clinical translation, and prospects for the treatment of lysosomal storage disorders","volume":"23","author":"Parenti","year":"2015","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib157","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012836","article-title":"The rapidly evolving view of lysosomal storage diseases","volume":"13","author":"Parenti","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib158","first-page":"102","article-title":"Lysosomal storage disease: revealing lysosomal function and physiology","volume":"25","author":"Parkinson-Lawrence","year":"2010","journal-title":"Physiol. (Bethesda)"},{"key":"10.1016\/j.neubiorev.2026.106931_bib159","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/B978-0-444-59565-2.00039-3","article-title":"Gangliosidoses","volume":"113","author":"Patterson","year":"2013","journal-title":"Handb. Clin. Neurol."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib160","first-page":"1","article-title":"The impact of the speech systems approach on intelligibility for children with cerebral palsy: a secondary analysis","volume":"10","author":"Pennington","year":"2023","journal-title":"Effic. Mech. Eval."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106931_bib161","article-title":"Speech therapy for children with dysarthria acquired before three years of age","author":"Pennington","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.neubiorev.2026.106931_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072533","article-title":"Metabolomic studies of lipid storage disorders, with special reference to niemann-pick type C disease: a critical review with future perspectives","volume":"21","author":"Percival","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.neubiorev.2026.106931_bib163","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S2468-1253(17)30052-3","article-title":"Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency","volume":"2","author":"Pericleous","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib164","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1044\/2023_AJSLP-22-00205","article-title":"Precision medicine as a new frontier in speech-language pathology: how applying insights from behavior genomics can improve outcomes in communication disorders","volume":"32","author":"Peter","year":"2023","journal-title":"Am. J. Speech-Lang. Pathol."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106931_bib165","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1044\/2021_AJSLP-21-00098","article-title":"Toward preventing speech and language disorders of known genetic origin: first post-intervention results of babble boot camp in children with classic galactosemia","volume":"30","author":"Peter","year":"2021","journal-title":"Am. J. Speech-Lang. Pathol."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib166","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2009.07.003","article-title":"Miglustat in patients with Niemann-Pick disease type C (NP-C): a multicenter observational retrospective cohort study","volume":"98","author":"Pineda","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib167","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrd.2017.214","article-title":"Emptying the stores: lysosomal diseases and therapeutic strategies","volume":"17","author":"Platt","year":"2018","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib168","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J. Cell. Biol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib169","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neubiorev.2026.106931_bib170","series-title":"Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)","author":"Randolph","year":"1998"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib171","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s12070-023-04144-y","article-title":"Audiological and speech and language characteristics of a case with Hunter\u2019s syndrome","volume":"76","author":"Rao","year":"2024","journal-title":"Indian. J. Otolaryngol. Head. & Neck Surg."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib172","first-page":"663","article-title":"The GM1 and GM2 gangliosidoses: natural history and progress toward therapy","volume":"13","author":"Regier","year":"2016","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.neubiorev.2026.106931_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105360","article-title":"Lysosome dysfunction as a cause of neurodegenerative diseases: lessons from frontotemporal dementia and amyotrophic lateral sclerosis","volume":"154","author":"Root","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib174","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/2050571X.2019.1622832","article-title":"The It Takes Two to Talk\u00ae \u2013 The Hanen Program\u00ae for Parents: impacts on child behaviour and social-emotional functioning","volume":"23","author":"Rose","year":"2020","journal-title":"Speech Lang. Hear."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib175","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ymgme.2021.06.008","article-title":"Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis","volume":"133","author":"Rowe","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106931_bib176","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/mds.20593","article-title":"Dystonia and parkinsonism in GM1 type 3 gangliosidosis","volume":"20","author":"Roze","year":"2005","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib177","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/humu.20636","article-title":"NPC-db, a Niemann-Pick type C disease gene variation database","volume":"29","author":"Runz","year":"2008","journal-title":"Human. Mutat."},{"key":"10.1016\/j.neubiorev.2026.106931_bib178","series-title":"The Social Communication Questionnaire (SCQ): Manual","author":"Rutter","year":"2003"},{"key":"10.1016\/j.neubiorev.2026.106931_bib179","article-title":"Utilizing telehealth to create a clinical model of care for patients with Batten disease and other rare diseases","volume":"2","author":"Scherr","year":"2021","journal-title":"Ther. Adv. Rare Dis."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib180","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/brain\/awac379","article-title":"Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial","volume":"146","author":"Schiffmann","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib181","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-025-03654-y","article-title":"Gaucher disease type 3 from infancy through adulthood: a conceptual model of signs, symptoms, and impacts associated with ataxia and cognitive impairment","volume":"20","author":"Schiffmann","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib182","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1044\/1058-0360(2008\/021)","article-title":"Effects of augmentative and alternative communication intervention on speech production in children with autism: a systematic review","volume":"17","author":"Schlosser","year":"2008","journal-title":"Am. J. Speech Lang. Pathol."},{"key":"10.1016\/j.neubiorev.2026.106931_bib183","article-title":"Motor control and learning: a behavioral emphasis","author":"Schmidt","year":"2018","journal-title":"Human. Kinet."},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106931_bib184","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia","volume":"66","author":"Schmitz-H\u00fcbsch","year":"2006","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.beem.2014.10.002","article-title":"Types A and B Niemann-Pick disease","volume":"29","author":"Schuchman","year":"2015","journal-title":"Best. Pract. & Res. Clin. Endocrinol. & Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib186","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1474-4422(23)00384-8","article-title":"Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study","volume":"23","author":"Schulz","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neubiorev.2026.106931_bib187","first-page":"73","article-title":"Characteristics of 26 patients with type 3 Gaucher disease: a descriptive analysis from the Gaucher outcome survey","volume":"14","author":"Schwartz","year":"2018","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"s455","key":"10.1016\/j.neubiorev.2026.106931_bib188","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","article-title":"A clinical study of 77 patients with mucopolysaccharidosis type II","volume":"96","author":"Schwartz","year":"2007","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.neubiorev.2026.106931_bib189","series-title":"NCS","article-title":"Clinical Evaluation of Language Fundamentals Fifth Edition (CELF-5)","author":"Semel","year":"2013"},{"key":"10.1016\/j.neubiorev.2026.106931_bib190","article-title":"Natural history, clinical symptoms, and cognitive development of Japanese patients with mucopolysaccharidosis III","volume":"45","author":"Seo","year":"2025","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib191","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2021.03.002","article-title":"The natural history of neurocognition in MPS disorders: A review","volume":"133","author":"Shapiro","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2026.106931_bib192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2017.08.009","article-title":"Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations - neurological signs and symptoms","volume":"122","author":"Shapiro","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2026.106931_bib193","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2015.11.079","article-title":"A prospective natural history study of mucopolysaccharidosis type IIIA","volume":"170","author":"Shapiro","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.neubiorev.2026.106931_bib194","article-title":"Lysosomal storage disorders: from biology to the clinic with reference to India","volume":"9","author":"Sheth","year":"2023","journal-title":"Lancet Reg. Health Southeast. Asia"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib195","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s10803-016-2702-z","article-title":"Increasing responsive parent\u2013child interactions and joint engagement: comparing the influence of parent-mediated intervention and parent psychoeducation","volume":"46","author":"Shire","year":"2016","journal-title":"J. Autism Dev. Disord."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib196","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2005.12.009","article-title":"Founder mutation causing infantile GM1-gangliosidosis in the Gypsy population","volume":"88","author":"Sinigerska","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2026.106931_bib197","series-title":"Vineland II: Vineland adaptive behavior scales","author":"Sparrow","year":"2005"},{"key":"10.1016\/j.neubiorev.2026.106931_bib198","series-title":"Vineland Adaptive Behavior Scales Third Edition (Vineland-3)","author":"Sparrow","year":"2016"},{"issue":"11","key":"10.1016\/j.neubiorev.2026.106931_bib199","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11940-022-00736-1","article-title":"Pompe disease: a clinical, diagnostic, and therapeutic overview","volume":"24","author":"Stevens","year":"2022","journal-title":"Curr. Treat. Options Neurol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib200","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1044\/1092-4388(2012\/12-0094)","article-title":"A motor speech assessment for children with severe speech disorders: reliability and validity evidence","volume":"56","author":"Strand","year":"2013","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"24","key":"10.1016\/j.neubiorev.2026.106931_bib201","doi-asserted-by":"crossref","first-page":"476","DOI":"10.21037\/atm.2018.11.39","article-title":"Lysosomal storage disease overview","volume":"6","author":"Sun","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib202","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.457","article-title":"The developing human brain: age-related changes in cortical, subcortical, and cerebellar anatomy","volume":"6","author":"Sussman","year":"2016","journal-title":"Brain Behav."},{"key":"10.1016\/j.neubiorev.2026.106931_bib203","doi-asserted-by":"crossref","DOI":"10.1177\/2326409818765564","article-title":"Results from a 12-month open-label phase 1\/2 study of velaglucerase alfa in children and adolescents with type 3 Gaucher disease","volume":"6","author":"Tantawy","year":"2018","journal-title":"J. Inborn Errors Metab. Screen."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib204","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-018-0876-5","article-title":"Clinical presentation and outcome in infantile Sandhoff disease: a case series of 25 patients from Iranian neurometabolic bioregistry with five novel mutations","volume":"13","author":"Tavasoli","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib205","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/1460-6984.12280","article-title":"Parent-implemented home therapy programmes for speech and language: a systematic review","volume":"52","author":"Tosh","year":"2017","journal-title":"Int. J. Lang. & Commun. Disord."},{"issue":"10","key":"10.1016\/j.neubiorev.2026.106931_bib206","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.3390\/ijms24108844","article-title":"The spectrum of neurological and sensory abnormalities in gaucher disease patients: a multidisciplinary study (SENOPRO)","volume":"24","author":"Tullo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib207","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10545-009-9009-6","article-title":"Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry","volume":"33","author":"Tylki-Szyma\u0144ska","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2026.106931_bib208","series-title":"StatPearls","article-title":"Lysosomal Storage Disease","author":"V","year":"2023"},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib209","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10545-011-9404-7","article-title":"Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy","volume":"35","author":"van Gelder","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.neubiorev.2026.106931_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.101053","article-title":"Characterization of central manifestations in patients with Niemann-Pick disease type C","volume":"26","author":"van Gool","year":"2024","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106931_bib211","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tips.2021.11.005","article-title":"Targeting neurological abnormalities in lysosomal storage diseases","volume":"43","author":"van Gool","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-Pick disease Type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.neubiorev.2026.106931_bib213","series-title":"Handbook of Clinical Neurology","first-page":"1717","article-title":"Chapter 176 - Niemann\u2013Pick diseases","author":"Vanier","year":"2013"},{"issue":"6541","key":"10.1016\/j.neubiorev.2026.106931_bib214","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/376584a0","article-title":"Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis","volume":"376","author":"Vesa","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2026.106931_bib215","article-title":"Development and validation of the dysarthria impact scale","author":"Vogel","year":"2025","journal-title":"MedRxiv"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib216","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/14015439.2013.775332","article-title":"Monitoring change requires a rethink of assessment practices in voice and speech","volume":"39","author":"Vogel","year":"2014","journal-title":"Logop. Phoniatr. Vocology"},{"issue":"5","key":"10.1016\/j.neubiorev.2026.106931_bib217","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1007\/s12311-024-01675-0","article-title":"Optimizing communication in ataxia: a multifaceted approach to alternative and augmentative communication (AAC)","volume":"23","author":"Vogel","year":"2024","journal-title":"Cerebellum"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib218","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-5876(90)90215-D","article-title":"Degeneration of speech, language, and hearing in a patient with mucopolysaccharidosis VII","volume":"19","author":"Wallace","year":"1990","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"4","key":"10.1016\/j.neubiorev.2026.106931_bib219","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/17549507.2013.876662","article-title":"An evaluation of the effectiveness of PROMPT therapy in improving speech production accuracy in six children with cerebral palsy","volume":"16","author":"Ward","year":"2014","journal-title":"Int. J. Speech-Lang. Pathol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib220","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/17549507.2012.713393","article-title":"Kinematic changes in jaw and lip control of children with cerebral palsy following participation in a motor-speech (PROMPT) intervention","volume":"15","author":"Ward","year":"2013","journal-title":"Int. J. Speech-Lang. Pathol."},{"issue":"6","key":"10.1016\/j.neubiorev.2026.106931_bib221","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1542\/peds.2004-0887","article-title":"The natural history of type B Niemann-pick disease: results from a 10-year longitudinal study","volume":"114","author":"Wasserstein","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib222","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/gim.2015.25","article-title":"High incidence of unrecognized visceral\/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets","volume":"18","author":"Wassif","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.neubiorev.2026.106931_bib223","series-title":"Wechsler Preschool and Primary Scale of Intelligence","author":"Wechsler","year":"2012"},{"key":"10.1016\/j.neubiorev.2026.106931_bib224","series-title":"Wechsler Intelligence Scale for Children\u2013Fifth Edition (WISC-V","author":"Wechsler","year":"2014"},{"key":"10.1016\/j.neubiorev.2026.106931_bib225","series-title":"WAIS-IV\u00ae Wechsler Adult Intelligence Scale\u00ae","author":"Wechsler","year":"2008"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib226","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ymgme.2014.11.008","article-title":"The clinical management of type 2 Gaucher disease","volume":"114","author":"Weiss","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2026.106931_bib227","series-title":"Clinical Evaluation of Language Fundamentals-Preschool 3","author":"Wiig","year":"2020"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib228","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0251","article-title":"Group MfNI. developmental assessments in preterm children: a meta-analysis","volume":"138","author":"Wong","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.neubiorev.2026.106931_bib229","doi-asserted-by":"crossref","DOI":"10.1177\/2326409818788382","article-title":"An adapted clinical measurement tool for the key symptoms of CLN2 disease","volume":"6","author":"Wyrwich","year":"2018","journal-title":"J. Inborn Errors Metab. Screen."},{"issue":"12","key":"10.1016\/j.neubiorev.2026.106931_bib230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225071","article-title":"Significant hearing loss in Fabry disease: Study of the Danish nationwide cohort prior to treatment","volume":"14","author":"Yazdanfard","year":"2019","journal-title":"PLoS. One"},{"key":"10.1016\/j.neubiorev.2026.106931_bib231","article-title":"Multimodal non-invasive biomarker characterization of structural and","author":"Yekeduz","year":"2026","journal-title":"Funct. Alter. ADSS1 Myopathy"},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib232","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12883-023-03267-7","article-title":"Clinical and genetic features of a case with juvenile onset sandhoff disease","volume":"23","author":"Yin","year":"2023","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib233","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1044\/1092-4388(2001\/019)","article-title":"Relative treatment effects of two prelinguistic communication interventions on language development in toddlers with developmental delays vary by maternal characteristics","volume":"44","author":"Yoder","year":"2001","journal-title":"J. Speech Lang. Hear. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2026.106931_bib234","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3174\/ajnr.A2832","article-title":"Brain and spinal MR imaging findings in mucopolysaccharidoses: a review","volume":"34","author":"Zafeiriou","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib235","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70261","article-title":"Neuronal ceroid lipofuscinosis-concepts, classification, and avenues for therapy","volume":"31","author":"Zhang","year":"2025","journal-title":"CNS Neurosci. & Ther."},{"key":"10.1016\/j.neubiorev.2026.106931_bib236","series-title":"Preschool language scales\u2013Fifth edition (PLS-5","author":"Zimmerman","year":"2011"},{"issue":"2","key":"10.1016\/j.neubiorev.2026.106931_bib237","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/aut.2018.0007","article-title":"Augmentative and alternative communication for speaking autistic adults: overview and recommendations","volume":"1","author":"Zisk","year":"2019","journal-title":"Autism Adulthood"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976342600388X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014976342600388X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:41:34Z","timestamp":1790257294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014976342600388X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":237,"alternative-id":["S014976342600388X"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106931","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disruptions in speech, language and social communication in lysosomal storage diseases","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2026.106931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106931"}}